On atomic force microscopy and the constitutive behavior of living cells

por Na, S., Sun, Z., Meininger, G. A., Humphrey, J. D.
Publicado 2004

Effect of canagliflozin on serum uric acid in patients with type 2 diabetes mellitus

por Davies, M. J., Trujillo, A., Vijapurkar, U., Damaraju, C. V., Meininger, G.
Publicado 2015

Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes on background metformin and pioglitazone

por Forst, T, Guthrie, R, Goldenberg, R, Yee, J, Vijapurkar, U, Meininger, G, Stein, P
Publicado 2014

Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

por Lavalle-González, F. J., Januszewicz, A., Davidson, J., Tong, C., Qiu, R., Canovatchel, W., Meininger, G.
Publicado 2013

Efficacy and safety of canagliflozin monotherapy in subjects with type 2 diabetes mellitus inadequately controlled with diet and exercise

por Stenlöf, K, Cefalu, W T, Kim, K-A, Alba, M, Usiskin, K, Tong, C, Canovatchel, W, Meininger, G
Publicado 2013

Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Di...

por Schernthaner, G, Gross, JL, Rosenstock, J, Guarisco, M, Fu, M, Yee, J, Kawaguchi, M, Canovatchel, W, Meininger, G
Publicado 2013

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease

por Yale, J-F, Bakris, G, Cariou, B, Yue, D, David-Neto, E, Xi, L, Figueroa, K, Wajs, E, Usiskin, K, Meininger, G
Publicado 2013

Efficacy and safety of canagliflozin in patients with type 2 diabetes mellitus inadequately controlled with metformin and sulphonylurea: a randomised trial

por Wilding, J P H, Charpentier, G, Hollander, P, González-Gálvez, G, Mathieu, C, Vercruysse, F, Usiskin, K, Law, G, Black, S, Canovatchel, W, Meininger, G
Publicado 2013